MRNA vs RLI · rev $145.0M vs P/E 24, rev $999.4M
Moderna Inc (MRNA) versus RLI Corp (RLI) — a side-by-side from cached financials, not a winner call.
Moderna Inc (MRNA) is a biotechnology company listed on NASDAQ. It is led by Stéphane Bancel M.B.A..
RLI Corp (RLI) is a insurance - property & casualty company listed on US.
Latest reported MRNA revenue for 2026-06-30 was $145.0M. Net income was -$782.0M. Revenue was down 62.7% from 2026-03-31 to 2026-06-30. MRNA currently screens at market cap $24.52B.
Latest reported RLI revenue for 2026-06-30 was $999.4M. Net income was $222.9M. RLI currently screens at market cap $6.58B and trailing P/E 23.7.
MRNA currently screens at market cap $24.52B. RLI currently screens at market cap $6.58B and trailing P/E 23.7.
Not investment advice. Open the MRNA and RLI stock pages for the full models.
Not investment advice.